Let’s discuss how Tardive Dyskinesia (TD) affects your life and what you can do to overcome these difficulties.
Biosciences announced the initiation of a Phase 1 clinical study to evaluate the safety, tolerability, pharmacokinetics and ...
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the initiation of a Phase 1 clinical study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results